RECOVAC Repeated Vaccination Study

PHASE4CompletedINTERVENTIONAL
Enrollment

336

Participants

Timeline

Start Date

October 21, 2021

Primary Completion Date

March 12, 2022

Study Completion Date

March 12, 2022

Conditions
Covid19Kidney DiseasesVaccine Response ImpairedSARS-CoV2 Infection
Interventions
BIOLOGICAL

mRNA-1273

SARS-CoV-2 vaccination

BIOLOGICAL

Ad26.COV2.S vaccine

SARS-CoV-2 vaccination

Trial Locations (4)

Unknown

Radboud umc, Nijmegen

Amsterdam UMC, Amsterdam

Erasmus mc, Rotterdam

University Medical Center Groningen, Groningen

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Radboud University Medical Center

OTHER

collaborator

Erasmus Medical Center

OTHER

collaborator

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

OTHER

collaborator

ZonMw: The Netherlands Organisation for Health Research and Development

OTHER

lead

University Medical Center Groningen

OTHER